논문 업적

  1. home
  2. KCSG 연구참여
  3. 논문 업적
번호 Study Code 질병분과 저널 제목 제1저자 교신저자 link
75 KCSG PC17-01 완화의료 Cancer Res Treat. 2019 Oct;51(4):1632-1638 Feasibility Study of Physician Orders for Life-Sustaining Treatment for
Patients with Terminal Cancer
안호정 고수진
74 KCSG PC13-09 완화의료 J Geriatr Oncol. 2019 Sep;10(5):749-756 Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors 김세현 김지현
73 KCSG BR13-11 유방암 Breast Cancer Res Treat. 2019 Nov;178(2):367-377 Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11). 김지연, 이유진 정경해, 박연희
72 KCSG GU17-03 비뇨기/부인암 Cancer Med. 2019 Sep;8(12):5431-5437 Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03 배우균, 이효진 정현애, 변재호
71 KCSG ST13-10 위암 Contemp Clin Trials Commun. 2017 Aug 18;8:55-61 Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial 이근욱 최인실
70 ST06-01 위암 J Cancer Res Clin Oncol. 2014 Feb;140(2):319-28 Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study(START) Wasaburo Koizumi Masashi Fujii
69 KCSG GU11-03 비뇨기/부인암 Cancer Res Treat Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma 이기쁨 라선영
68 KCSG ST10-01 위암분과 Oncologist. 2018 Aug 20. pii: doi: 10.1634/theoncologist.2018-0142. [Epub ahead of print] A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01) 이근욱, 맹치훈 조재용
67 N/A 위암 Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) 정민규 라선영, 조재용
66 KCSG HN15-16 두경부식도암분과 Cancer Res Treat. 2018 May 9. doi: 10.4143/crt.2018.012. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma 임선민, 조상희, 황인규 윤환중, 김상우, 김혜련
65 KCSG BR10-04 유방암분과 Eur J Cancer. 2018 Nov;103:127-136. doi: 10.1016/j.ejca.2018.08.004. Epub 2018 Sep 14. Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study). 김지연 임영혁
64 KCSG LU12-13 폐암분과 Cancer Res Treat. 2018 Sep 3. doi: 10.4143/crt.2018.324. A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13 유쾌한 안명주
63 KCSG PC13-02 완화의료 Support Care Cancer. 2017 Dec;25(12):3759-3767. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients 오소연 신상원
62 KCSG CO14-03 대장암 Int J Radiat Boil Phys . 2018 Apr 11. doi.org/10.1016/j.ijrobp.2018.04.013 A Randomized Phase II Trial of Consolidation Chemotherapy after Preoperative Chemoradiation versus Chemoradiation alone for Locally Advanced Rectal Cancer: KCSG CO 14-03 김선영 백지연
61 KCSG PC13-09 완화의료 Br J Cancer. 2018 Mar 26. doi: 10.1038/s41416-018-0037-6. [Epub ahead of print] Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study. 김진원 김지현
60 KCSG LU12-07 폐암 Br J Cancer. 2018 Mar 6;118(5):648-653. doi: 10.1038/bjc.2017.465. Epub 2018 Jan 30. Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07). 선종무 안명주
59 KCSG BR11-01 유방암 Cancer Res Treat. 2018 Feb 14. doi: 10.4143/crt.2017.562. [Epub ahead of print] Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01). 박인혜 노정실
58 KCSG CO12-04 대장암 Korean J Intern Med 2017;kjim.2016.348. The impact of primary tumor location in patients
with metastatic colorectal cancer: a Korean
Cancer Study Group CO12-04 study.
변재호 박영석
57 KCSG GU11-05 비뇨기/부인암 Cancer Res Treat. 2018 Jan 2. doi: 10.4143/crt.2017.438. [Epub ahead of print] Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05). 최윤지 박경화
56 KCSG ST14-11 위암 Gastric Cancer. 2018 Jan 25. doi: 10.1007/s10120-018-0794-1. [Epub ahead of print] Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11 김형수, 류민희 장대영
55 KCSG BR13-11 유방암 European Journal of Cancer 86 (2017) 385-393 Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer 박연희 정경해
54 KCSG HN10-02 두경부암 Radiother Oncol. 2016 Feb;118(2):244-50 Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02). 이지연 안명주, 안용찬
53 KCSG LY16-01 림프종 Cancer Research and Treatment doi: https://doi.org/10.4143/crt.2017.172 [Epub] Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01 최정혜 최정혜
52 KCSG LU13-08 폐암 J Clin Oncol. 2017 Aug 10;35(23):2613-2618 Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. 임선민, 김혜련 안명주, 조병철
51 KCSG GU14-08 비뇨기/부인암 Cancer Research and Treatment 2016; 48(4): 1286-1292. Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08 김기향 라선영
50 KCSG LU05-04 폐암 J Clin Oncol. 2015 Aug 20;33(24):2660-6. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. 안진석 박근칠
49 KCSG 0806 폐암 Lung Cancer. 2016 Mar;93:1-8. A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806). 임선민 김주항
48 KCSG PC10-09 완화의료 Support Care Cancer. 2016 Apr;24(4):1709-17 A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09. 이기형 오도연, 임석아
47 KCSG HN14-01 두경부암 Cancer. 2017 Jan 19. doi: 10.1002/cncr.30537. [Epub ahead of print] Clinical Trial of Nintedanib in Patients With Recurrent
or Metastatic Salivary Gland Cancer of the Head and Neck:A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)
김유진 안명주
46 KCSG HN12-02 두경부암 Clin Cancer Res. 2015 Feb 1;21(3):544-52. Phase II Clinical and Exploratory Biomarker
Study of Dacomitinib in Patients with Recurrent
and/or Metastatic Squamous Cell Carcinoma of
Head and Neck
김한상 조병철
45 KCSG LU12-01 폐암 Oncotarget. 2016 Nov 3. doi:10.18632/oncotarget.13056. [Epub ahead of print] A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum- based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) 김혜련, 장정순 김상위, 조병철
44 KCSG HN12-08 두경부암 Eur J Cancer. 2015 Aug;51(12):1588-95. An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer 임선민 김혜련, 조병철
43 KCSG HN13-06 두경부암 Cancer Res Treat. 2016 Jul 28. doi: 10.4143/crt.2016.121. [Epub ahead of print] Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer 김미소 김범석
42 KCSG HN11-08 두경부암 Clin Cancer Res February 1, 2015 21:544-552 Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck 김한상 조병철
41 KCSG PC10-21 완화의료 Oncologist. 2015 Dec;20(12):1440-7. Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21 김효정 강진형
40 KCSG HN10-02 두경부암 Radiother Oncol. 2016 Feb;118(2):244-50. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02) 이지윤, 선종무 안명주,안용찬
39 KCSG HN10-03 두경부암 Ann Oncol. 2013 Dec;24(12):3089-94 A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes. 임선민, 장현 조병철
38 KCSG GY10-10 비뇨기/부인암 Gynecol Oncol. 2015 Feb;136(2):212-7 Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10 홍숙희 변재호
37 KCSG GU10-17 비뇨기/부인암 Br J Cancer. 2015 Jan 20;112(2):260-5 Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17). 최영진 이재련
36 KCSG GU10-15 비뇨기/부인암 Br J Cancer. 2014 May 13;110(10):2472-8 Gemcitabine?oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed 이재련 이재련
35 KCSG BR09-05 유방암 Ann Oncol. 2013 Jun;24(6):1485-90 Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). 김혜련, 정경해 손주혁
34 KCSG LU08-01 폐암 Cancer. 2012 Dec 15;118(24):6234-42 Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial. 선종무 안명주
33 KCSG HN07-01 두경부암 Eur J Cancer. 2012 Nov;48(17):3198-204 A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01). 지준호 안명주
32 KCSG BR07-02 유방암 J Clin Oncol. 2013 May 10;31(14):1732-9 Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. 박연희 임영혁
31 KCSG BR07-01 유방암 Breast Cancer Res Treat. 2012 Apr;132(2):589-600 Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01. 임석아 노정실
30 KCSG HB07-01 간담췌암 Invest New Drugs (2012) 30:1164?74 A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research 오도연 방영주
29 KCSG CO06-01 대장암 Am J Clin Oncol 2013;36:565?571 Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01. 홍용상 김태원
28 KCSG CO06-02 대장암 Am J Clin Oncol. 2014 Feb;37(1):19-23 A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group. 홍용상 김태원
27 KCSG ST06-03 위암 Br J Cancer. 2009 ;100(2):298-304 Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. 한세원 김태유
26 KCSG ST06-02 위암 Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72 A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. 최윤희, 오상철 강혜진
25 KCSG LU06-01 폐암 Lung Cancer. 2009 Dec;66(3):338-43 Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: a prospective, multicenter trial. 이희영 박근칠
24 KCSG ST06-04 위암 Invest New Drugs. 2011 Apr;29(2):366-73 A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer. 김철 강윤구
23 KCSG ST06-01 위암 Int J Clin Oncol. 2008 Jun;13(3):201-5 (REVIEW ARTICLE) Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study). - -
22 KCSG BR06-01 유방암 Breast Cancer Res Treat. 2011;125(1):99-106 Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01). 김정은 안진희
21 KCSG HB06-02 간담췌암 Cancer Chemother Pharmacol. 2010 Mar;65(4):641-7 Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. 장정순 장정순
20 KCSG HC06-01 완화의료 Cancer Res Treat. 2008 Jun;40(2):87-92 Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. 김도연 김도연
19 KCSG CO05-01 대장암 Cancer Chemother Pharmacol. 2009 Sep;64(4):657-63 Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. 이지연 강원기
18 KCSG LU05-03 폐암 Clin Cancer Res. 2010 Feb 15;16(4):1307-14 Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy. 이대호, 박근칠 김상위
17 KCSG ST05-01 위암 Cancer Chemother Pharmacol. 2009 May;63(6):1083-90 A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. 이재진 김시영
16 KCSG ST05-02 위암 Asia Pac J Clin Oncol. 2009;5(1):46?54 Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02 강혜진 류백렬
15 KCSG LU05-01 폐암 J Thorac Oncol. 2009;4(9):1136-43 Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group. 엄지은, 박병배 박근칠
14 KCSG LU05-02 폐암 Clin Cancer Res. 2008;14(12):3860-6 Are There Any Ethnic Differences in Molecular Predictors of Erlotinib Efficacy in Advanced Non-Small Cell Lung Cancer? 안명주 박근칠
13 KCSG LY04-03 림프종 Oncologist. 2014 Nov;19(11):1129-30 A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. 김태민 허대석
12 KCSG ST04-01 위암 Jpn J Clin Oncol. 2007 Jul;37(7):501-8 Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial. 김열홍 Yuh Sakata
11 IRB04-01 위암 Asia Pac J Clin Oncol. 2014 Mar;10(1):38-52 Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics 방영주 John Zalcberg
10 KCSG HB03-01 간담췌암 Cancer Chemother Pharmacol. 2008 Oct;62(5):763-8 A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer. 송홍석 김시영
9 KCSG ST03-03 (KCSG 03-06-25) 위암 Cancer Chemother Pharmacol. 2008 Jul;62(2):263-70 Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study. 김열홍 방영주
8 KCSG LU02-01 (KCSG 02-09-17) 폐암 J Clin Oncol. 2007;25:5233-9 Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. 박준오 박근칠
7 KCSG 02-11-08 간담췌암 Cancer Chemother Pharmacol. 2008 Jan;61(1):47-52 Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. 이지연 김준석
6 KCSG ST02-01 (KCSG 02-10-31) 위암 Cancer Res Treat. 2009;41(1):12-8 Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer 이경훈 김훈교
5 KCSG CO01-01 (KCSG 01-11-17) 대장암 Acta Oncol. 2005;44(3):230-5 Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial. 김태원 강원기
4 KCSG BR01-01 (KCSG 01-10-05) 유방암 Oncol Rep. 2005 Aug;14(2):481-7 Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor. 임석아 김성배
3 N/A 림프종 Ann Oncol. 2008 Aug;19(8):1477-84 Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. 김태민 허대석
2 N/A 폐암 Lung Cancer. 2006 Apr;52(1):75-81 Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. 김지현 허대석
1 N/A 비뇨기/부인암 Cancer Res Treat. 2014;46(2):141-147 Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. 권경아 라선영